Smart Inhalers Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Sensirion, 3M (NYSE: MMM), Adherium Limited (ASX: ADR), AstraZeneca (LON: AZN)

Registering a CAGR of 40.2% over the forecast period, the market value of Smart Inhalers is expected to reach US$ 4750.50 million in the year 2027.

Smart Inhalers Market Overview

Smart inhalers are an improvement over traditional inhalers in that they use connecting technology as well as sensors to collect and store information about the patient's habits and needs. This connectivity technology assists in informing patients about the need to refill inhalers and when to take medication, as well as increasing the dosage based on the patient's condition.

The increasing awareness of the benefits of smart inhalers over conventional inhalers, ongoing technological advancements in smart inhalers, and the rising prevalence of respiratory disorders are some of the major drivers driving the market growth during the forecast period. However, the high cost of smart inhalers, data security concerns associated with security devices, and regulating government policies may stymie the market for smart inhaler devices. The use of digital inhalers is expected to rise over the next ten years as collaborations between digital and pharmaceutical companies expand. Smart inhaler manufacturers are focusing on collaborations and mergers to combine the best technologies to create the best smart inhaler product. Adoption of digitally enhanced products is expected to rise, which will drive demand for smart inhalers.

As people become more aware of the benefits of smart inhalers, demand for them is expected to rise. More healthcare professionals are improving their services by incorporating smart technology, and smart inhalers are no exception. Smart inhalers improve medication adherence, enable cost-effective drug tracking and management, lower treatment costs, and provide detailed insights into patient data to optimize treatment and reduce steroid use.

Who are the Major Players in the Smart Inhalers Market?

The global Smart Inhalers includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Sensirion, 3M (NYSE: MMM), Adherium Limited (ASX: ADR), AstraZeneca (LON: AZN), Boehringer Ingelheim, Cohero Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, OPKO Health (Inspiro Medical Ltd.), Philips Respironics, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group and others.

Industry News and Updates:

Propeller Health Enters Japan with Digital Health Sensor for New Enerzair® and Atectura® Breezhaler® Asthma Medications

26/8/2020--Propeller Health announced a partnership with Novartis to connect the Propeller digital health platform to Enerzair® and Atectura® Breezhaler®, two new once-daily Novartis medications available outside the United States to treat uncontrolled asthma.

Aptar and Sonmol Partner to Develop Digital Platform for Respiratory-Related Therapies

21 April 2020-- Aptar and Sonmol, a leading Chinese digital respiratory therapeutics company, have announced a partnership to create a digital therapies and services platform for respiratory and other diseases.

The initial focus of this collaboration will be on connecting connected drug delivery devices and the digital platform for asthma and chronic obstructive pulmonary disease (COPD). Aptar Pharma and Sonmol will collaborate to expand Sonmol's platform services, enabling remote patient monitoring, improving patient and physician interactions, increasing patient engagement and adherence, and improving health outcomes.

Teva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate) Inhalation Powder

FEBRUARY 24, 2020-- Teva Respiratory, LLC, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced that the FDA has approved ArmonAir® DigihalerTM (fluticasone propionate) Inhalation Powder, an inhaled corticosteroid (ICS) delivered via Teva's DigihalerTM device, which contains built-in sensors and connects to a companion mobile application that provides information on inhaler use to people with asthma. ArmonAir® DigihalerTM is approved for the maintenance treatment of asthma in patients aged 12 and up. ArmonAir® DigihalerTM is not intended to treat acute bronchospasm.

What are the major Applications, Types, and Regions for the Smart Inhalers Market?

The market is segmented based on the type, applications, companies, and regions.

By Type, it is segmented into

• Digital Dose Inhalers


• Dry Powder Inhalers


• Nebulizers


• Other

By Application, it is segmented into

• Asthma


• COPD


• Other

Smart Inhalers Market Regional Analysis

The North American smart inhalers industry was worth more than USD 500 million in 2021 and is expected to grow rapidly during the analysis period. The growth is primarily due to continuous technological advancements in the respiratory disease management industry, which, together with the affordability of smart inhalers among the target population, is expected to fuel the regional smart inhalers market outlook. Furthermore, the region's growing disposable income and high healthcare expenditure on health care management will drive North American market forecasts. Furthermore, the region's strong presence of established market players, combined with a favorable regulatory environment, leads to a number of product approvals and launches, particularly in the United States. As a result, the market size in North America is increasing.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Smart Inhalers Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Smart Inhalers Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Smart Inhalers Market report scope?

Scope of the Report covers the Smart Inhalers Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Smart Inhalers Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.

Report Attributes	Report Details
Report Title	Smart Inhalers Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Sensirion, 3M (NYSE: MMM), Adherium Limited (ASX: ADR), AstraZeneca (LON: AZN)
Forecast Period 2022 to 2027 CAGR	CAGR of 40.2% over the forecast period (2022-2027)
By Type	Digital Dose Inhalers Dry Powder Inhalers Nebulizers Other
By Application	Asthma COPD Other
By Companies	Sensirion, 3M, Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, OPKO Health (Inspiro Medical Ltd.), Philips Respironics, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group
Regions Covered	North America Europe Asia-Pacific Rest of the World
Countries Covered	US Canada Germany France UK Italy Spain Rest of Europe China Japan India Australia South Korea Rest of Asia-Pacific Middle East & Africa Latin America
Base Year	2022
Historical Year	2017 to 2021
Forecast Year	2022 to 2027
Number of Pages	124
Customization Available	Yes, the report can be customized as per your needs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key Takeaways from this Smart Inhalers Report

• Evaluate Smart Inhalers market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at the country level - for product types, end-use applications, and different industries verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.


• Get in-depth insights on your competitor’s performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies to your processes.


• Get a quick outlook on the Smart Inhalers market entropy – M&As, deals, partnerships, and product launches of all key players for the past 5 years.


• Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.

Frequently Asked Questions

What is the study period of this market?

The Smart Inhalers Market is studied from 2017 - 2027.

What is the growth rate of the Smart Inhalers Market?

The Smart Inhalers Market is growing at a CAGR of 40.2% over the next 5 years.

Who are the key players in Smart Inhalers Market?

Sensirion, 3M, Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, OPKO Health (Inspiro Medical Ltd.), Philips Respironics, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group

What regions does this Smart Inhalers Market report cover?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Smart Inhalers Market?

Digital Dose Inhalers, Dry Powder Inhalers, Nebulizers, Other

What are the major end-use applications of Smart Inhalers Market?

Asthma, COPD, Other

 

All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.